Interaction of meningococcal group B monoclonal antibody and its Fab fragment with alpha 2-8-linked sialic acid polymers: requirement of a long oligosaccharide segment for binding

Molecular Immunology
J HäyrinenJukka Finne

Abstract

Mouse monoclonal IgG2a antibody (735D4) and other antibodies to the capsular polysaccharide of group B meningococci have been shown to require an unusually long segment of the alpha 2-8-linked N-acetylneuraminic acid polymer for binding. This property may be due to a conformational nature of the polysaccharide epitope recognized, or alternatively due to the requirement of bivalent binding of the antibody to the polysaccharide. In order to study the binding requirements, Fab fragments were prepared from the monoclonal antibody and their binding to alpha 2-8-linked sialic acid polymers of different lengths was studied. Both the intact antibody and its Fab fragment bound to sialic acid poly- and oligomers to similar extents, the critical chain length being about 10 sialyl units for both molecules. This excluded bivalency as the explanation for the requirement of a long oligosaccharide segment for binding. Although the binding was enhanced with increasing chain length, the first 10 monosaccharides were calculated to contribute to more than 90% of the total binding energy. This is in agreement with an oligosaccharide segment with defined conformational epitope binding to the antibody combining site. The antibody preparations also bo...Continue Reading

References

Jan 1, 1987·Annual Review of Biophysics and Biophysical Chemistry·R A MariuzzaR J Poljak
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·S SheriffD R Davies
Jan 25, 1986·Lancet·M R Lifely, C Moreno
Apr 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·J RothJ Finne
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M R WesselsD L Kasper
Feb 1, 1966·Proceedings of the National Academy of Sciences of the United States of America·M Sela, E Mozes
Jan 1, 1983·Methods in Enzymology·P J Munson
May 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stefan RutkowskiMichael Grotzer

❮ Previous
Next ❯

Citations

Jul 18, 1995·Proceedings of the National Academy of Sciences of the United States of America·J NakayamaM Fukuda
Apr 23, 2005·Infection and Immunity·Michael J CieslewiczCraig E Rubens
Aug 23, 2005·Infection and Immunity·Martine P Bos, Jan Tommassen
Jul 5, 2005·Expert Opinion on Investigational Drugs·R K Sood, A Fattom
Nov 7, 2014·Critical Reviews in Biochemistry and Molecular Biology·Karen J ColleyChihiro Sato
Jan 1, 1991·The International Journal of Biochemistry·C M Regan
Jul 1, 1991·Differentiation; Research in Biological Diversity·P M LackieJ Roth
Oct 24, 1998·The Journal of Biological Chemistry·J ToikkaJ Finne
Feb 23, 1995·Nature·M EckhardtR Gerardy-Schahn
Dec 11, 2019·International Journal of Molecular Sciences·Frieder SimonRüdiger Horstkorte
Jan 26, 1996·The Journal of Biological Chemistry·J Nakayama, M Fukuda
Oct 1, 1994·Clinical Microbiology Reviews·J Diaz Romero, I M Outschoorn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.